Opendata, web and dolomites


Lifecare’s Sencell sensor is an implantable micro-sensor for subcutaneous location, long time, continuous, wireless, real time monitoring of interstitial glucose for diabetes management.

Total Cost €


EC-Contrib. €






 Sencell16 project word cloud

Explore the words cloud of the Sencell16 project. It provides you a very rough idea of what is the project "Sencell16" about.

relayed    inside    body    prompting    enclosed    subcutaneously    proprietary    osmotic    induce    implanted    located    independently    suitable    autonomously    generate    signals    utilizes    cavity    sites    interstitial    cell    concanavalin    significantly    patented    reading    time    operation    sensors    automatically    transmitter    accurate    battery    wrist    dextran    blood    user    cona    places    enzymatic    translates    inner    covered    space    miniaturized    signal    intended    insulin    monitoring    semi    designed    sensor    fluid    glucose    sensitivity    wires    unlike    sencell    improves    longer    influence    hypoglycemia    skin    subcutaneous    substances    sugar    device    final    medical    alternatives    mobile    core    encased    noninvasively    pressure    function    arm    reducing    biocompatible    insertion    permeable    entire    hyperglycemia    protruding    transducer    physical    doses    membrane    material    warning    contains    communication   

Project "Sencell16" data sheet

The following table provides information about the project.


Organization address
address: OVRE KRAKENES 17
city: BERGEN
postcode: 5152

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Norway [NO]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-08-01   to  2016-12-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIFECARE AS NO (BERGEN) coordinator 50˙000.00


 Project objective

The SENCELL Glucose Monitoring System includes an osmotic pressure sensor, transmitter and mobile medical application. The miniaturized sensor is designed to be implanted into the subcutaneous space of arm wrist or other suitable body sites and requires no battery or wires for the sensor operation and for communication with the transmitter. After insertion, the sensor is designed to function noninvasively, automatically, and continuously for a long term duration that is comparable or longer than existing product alternatives.

The miniaturized SENCELL is designed to continuously measure glucose in the interstitial fluid for a long term duration that is comparable or longer than existing product alternatives. Unlike currently used glucose sensors, the Sencell is intended to be implanted subcutaneously on the arm wrist or other subcutaneous places in the body with no sensor part protruding from the skin.

Encased in a biocompatible material, the device utilizes a unique osmotic pressure assessment technology, which translates the signal of a physical miniaturized osmotic pressure cell into an accurate glucose reading that can be used for determination of insulin doses and to generate warning signals in case of hypoglycemia or hyperglycemia development.

The inner core of the device is the unique and proprietary osmotic patented pressure cell, which is covered on one side by a semi-permeable membrane. The membrane is enclosed inside the top of a cavity where the pressure transducer is also located. The cavity contains Concanavalin A and Dextran.

The use of ConA/Dextran as enzymatic component significantly improves the sensitivity to changes in the blood sugar level while reducing the influence from other substances in the blood. In the final product, the measurement is then relayed to the transmitter. The entire measurement is designed to be done autonomously and independently without any prompting by the user. However, the user can induce a measurement at any time

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SENCELL16" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SENCELL16" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More